TY  - GEN
AU  - Shimizu,K
AU  - Hara,K
AU  - Yatabe,Y
TI  - Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission
SN  - 0925-5710
PY  - 1999///0422
KW  - Antigens, CD20
KW  - analysis
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Diagnosis, Differential
KW  - Doxorubicin
KW  - Epstein-Barr Virus Infections
KW  - diagnosis
KW  - Fatal Outcome
KW  - Female
KW  - Gene Rearrangement
KW  - Herpesvirus 4, Human
KW  - isolation & purification
KW  - Hodgkin Disease
KW  - Humans
KW  - Immunophenotyping
KW  - In Situ Hybridization
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - drug therapy
KW  - Lymphoma, Non-Hodgkin
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Neoplasms, Second Primary
KW  - Neoplastic Stem Cells
KW  - chemistry
KW  - Polymerase Chain Reaction
KW  - Prednisone
KW  - RNA, Viral
KW  - Receptors, Antigen, B-Cell
KW  - Reed-Sternberg Cells
KW  - Remission Induction
KW  - Vincristine
N1  - Publication Type: Case Reports; Journal Article; Review
ER  -